INCR

InterCure Ltd. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website intercure.co
Employees(FY) 370
ISIN IL0011063760

Performance

+11.38%

+7.97%

-19.89%

-34.93%

+15.52%

YTD

+16.41%

Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Advanced Technical Analysis

Technical Analysis of INCR 2024-12-20

The stock indicators reflect a neutral sentiment overall, with the Moving Average Score at 56, Oscillators Score at 60, and Technical Score at 58, suggesting a balanced market condition. While the Oscillators indicate a slightly bullish momentum, the other scores reinforce a cautious outlook, highlighting the need for further confirmation before...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of INCR

Stock Rank

Recent News & Updates

2024-12-19 19:32
InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility(Prnewswire)
2024-09-01 06:37
Weekly Roundup on the Cannabis Sector & Psychedelic Sector(Yahoo Finance)
2024-08-29 06:03
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million(Globenewswire)
2024-08-27 20:54
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany(Businesswire)
2024-05-21 18:45
InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference(Businesswire)
2024-04-30 20:27
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million(Businesswire)
2024-03-31 21:09
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million(Businesswire)
2024-03-21 23:58
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint(Businesswire)
2024-02-13 03:46
InterCure Provides an Update Regarding Nir Oz Facility(Globenewswire)
2024-01-30 20:27
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain(Globenewswire)
2023-10-31 04:39
InterCure Wins Cannolam Arbitration Proceeding(Globenewswire)
2023-10-17 05:04
InterCure Provides an Update Regarding the Security Situation in Israel(Globenewswire)
2023-08-31 07:45
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY(Yahoo Finance)
2023-07-10 05:00
InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE(Yahoo Finance)
2023-06-09 05:18
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger(Yahoo Finance)
2023-05-15 05:59
InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference(Yahoo Finance)
2023-05-15 05:45
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY(Yahoo Finance)
2023-05-14 20:30
InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business(Yahoo Finance)
2023-04-25 07:19
InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary(Yahoo Finance)
2023-04-24 05:59
InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel(Yahoo Finance)
2023-04-19 20:30
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries(Yahoo Finance)
2023-04-03 03:27
InterCure Reschedules 2022 Full Year Results Conference Call(Yahoo Finance)
2023-03-31 08:00
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results(Yahoo Finance)
2023-02-13 19:30
InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger(Yahoo Finance)
2023-01-31 19:30
InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)(Yahoo Finance)
2022-12-18 19:30
InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"(Yahoo Finance)
2022-12-07 20:30
InterCure to Participate in Cowen 5th Annual Cannabis Conference(Yahoo Finance)
2022-12-05 03:30
InterCure Announces the Withdrawal of a Class Action Lawsuit against it(Yahoo Finance)
2022-11-23 03:30
Update regarding Better Transaction(Yahoo Finance)
2022-11-16 19:17
Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies(Yahoo Finance)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.